Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer and the third leading
cause of cancer-related deaths. Therefore, there is an urgent need for a novel molecular …

Pancreatic ductal adenocarcinoma (PDAC) is one the most aggressive cancers and
characterized by a highly rigid and immunosuppressive tumor microenvironment (TME). The …

Simple Summary Radical pancreatectomies with superior mesenteric vein (SMV) resection
without portal-to-superior mesenteric vein (PV/SMV) reconstruction are scarcely discussed …

Background Pancreatic cancer has a high case fatality and treatment is known to improve
survival. It is unknown whether the time between diagnosis and treatment initiation (time-to …

The key challenge of cell-free tumor DNA (cftDNA) analysis in pancreatic ductal
adenocarcinoma (PDAC) is overcoming its low detection rate, which is mainly explained by …

Objectives: Pancreatic cancer is often diagnosed at advanced stages with high-case fatality.
Many tumors are not surgically resectable. We aimed to identify features associated with …

Background Interrupting chemotherapy may explain the reduced overall survival (OS) in
patients with pancreatic cancer (PC) with cholangitis. Endoscopic biliary decompression …

The generation of genetically engineered pig models that develop pancreas-specific tumors
has the potential to advance studies and our understanding of pancreatic cancer in humans …

Pancreatic cancer (PC) is a serious public health problem. The mortality rate of patients with
PC remains one of the highest among cancers. Early diagnosis of PC is challenging, so it is …

Рак поджелудочной железы (РПЖ) представляет серьезную проблему для
здравоохранения. Летальность больных РПЖ остается одной из самых высоких среди …